SLC7A3 and thyroid gland papillary carcinoma: This observation contrasts with a previous report showing that papillary thyroid carcinoma patients with high SLC7A3 expression have poor survival rates and another study indicating that SLC7A3 promotes tumor growth by increasing intracellular arginine to maintain mTORC1 activation [37].